drugset / Trial / NCT03485053

A Single Ascending Study of IOP Injection in Patients With Iron Deficient Anemia

NCT03485053 ↗

Phase 2 Terminated 49 enrolled MegaPro Biomedical Co. Ltd.
NaSingle-groupOpen-labelTreatment

Summary

The purpose is to evaluate the efficacy and safety of IOP Injection (MPB-1514) for the treatment of iron-deficient anemia (IDA).

Timeline

Start
2018-11-29
Primary completion
2020-09-30
Completion
2021-08-31

Outcome

Outcome not reported

Stopped: “Sponsor terminate the trial and will conduct a phase 2b clinical trial further”

Drugs

EvaluationDrugModalityDoseRoute
Subject MPB-1514 Unknown — Intravenous